{
    "id": "f430fac2-abe6-4751-ae53-723c0610a3f5",
    "indications": {
        "text": "diphenoxylate hydrochloride atropine sulfate indicated adjunctive therapy management diarrhea patients 13 years age older .",
        "doid_entities": [
            {
                "text": "diarrhea (DOID:13250)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_13250"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "tablets \u2014 round , white , searle debossed one side 61 side containing 2.5 mg diphenoxylate hydrochloride 0.025 mg atropine sulfate , supplied : ndc number size 59762-1061-1 bottle 100 59762-1061-2 bottle 1000",
    "adverseReactions": "diphenoxylate hydrochloride atropine sulfate contraindicated : \u2022pediatric patients less 6 years age due risks respiratory central nervous system ( cns ) depression ( ) . \u2022patients diarrhea associated pseudomembranous enterocolitis ( clostridium difficile ) enterotoxin-producing bacteria due risk gastrointestinal ( gi ) complications , including sepsis ( ) . \u2022patients known hypersensitivity diphenoxylate atropine . \u2022patients obstructive jaundice .",
    "ingredients": [
        {
            "name": "DIPHENOXYLATE HYDROCHLORIDE",
            "code": "W24OD7YW48",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_59784"
        },
        {
            "name": "ATROPINE SULFATE",
            "code": "03J5ZE7KA5",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_233047"
        },
        {
            "name": "ACACIA",
            "code": "5C5403N26O",
            "drugbank_id": "https://go.drugbank.com/drugs/DB10451"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "SORBITOL",
            "code": "506T60A25R",
            "drugbank_id": "https://go.drugbank.com/drugs/DB01638"
        },
        {
            "name": "SUCROSE",
            "code": "C151H8M554",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17992"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32178"
        }
    ],
    "organization": "Mylan Pharmaceuticals Inc.",
    "name": "Diphenoxylate Hydrochloride and Atropine Sulfate",
    "effectiveTime": "20250513",
    "indications_original": "Diphenoxylate hydrochloride and atropine sulfate is indicated as adjunctive therapy in the management of diarrhea in patients 13 years of age and older.",
    "warningsAndPrecautions_original": "Tablets \u2014 round, white, with SEARLE debossed on one side and 61 on the other side and containing 2.5 mg of diphenoxylate hydrochloride and 0.025 mg of atropine sulfate, supplied as:\n                  \n                     \n                     \n                     \n                        \n                           \n                              NDC Number\n                           \n                           \n                              \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Size\n                           \n                        \n                     \n                     \n                        \n                           \n                              59762-1061-1\n                           \n                           \n                              bottle of 100\n                           \n                        \n                        \n                           \n                              59762-1061-2\n                           \n                           \n                              bottle of 1000",
    "adverseReactions_original": "Diphenoxylate hydrochloride and atropine sulfate is contraindicated in:\n                  \n                     \n                        \u2022Pediatric patients less than 6 years of age due to the risks of respiratory and central nervous system (CNS) depression (see \n                           WARNINGS\n                        ).\n                     \n                        \u2022Patients with diarrhea associated with pseudomembranous enterocolitis (Clostridium difficile) or other enterotoxin-producing bacteria due to the risk of gastrointestinal (GI) complications, including sepsis (see \n                           WARNINGS\n                        ). \n                     \n                        \u2022Patients with known hypersensitivity to diphenoxylate or atropine.\n                     \n                        \u2022Patients with obstructive jaundice.",
    "drug": [
        {
            "name": "Diphenoxylate Hydrochloride and Atropine Sulfate",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_4639"
        }
    ]
}